SECsense Logo

Emergent Biosolutions Inc. 8-K Report: Key Updates as of January 15, 2025

$EBS
Form 8-K
Filed on: 2025-01-15
Source
Emergent Biosolutions Inc. 8-K Report: Key Updates as of January 15, 2025

Here is a summary of the key information extracted from the provided financial report section:

  1. Company Information:
  • Name: Emergent Biosolutions Inc.
  • CIK (Central Index Key): 0001367644
  • SEC File Number: 001-33137
  • EIN (Employer Identification Number): 14-1902018
  • Address: 300 Professional Drive, Gaithersburg, MD 20879
  • Phone Number: (240) 631-3200
  1. Filing Type:
  • Filing Form: 8-K (which is used for reporting unscheduled material events or corporate changes)
  1. Filing Date:
  • Date of Report: January 15, 2025
  1. Stock Information:
  • Common Stock: $0.001 par value per share
  • Ticker Symbol: EBS
  • Stock Exchange: NYSE (New York Stock Exchange)
  1. Period of Reporting:
  • Report Duration: The report pertains to the date January 15, 2025.

Insights:

  • Emergent Biosolutions Inc. is publicly traded on the NYSE under the ticker symbol EBS, indicating it is a well-established company in the biopharmaceutical sector.
  • The 8-K filing suggests that the company may have experienced a significant event or change that warranted immediate disclosure to shareholders and the public.
  • The document indicates that the company is in compliance with SEC reporting requirements, as evidenced by the structured format of the filing.

This information is crucial for investors and analysts tracking the company’s performance and any recent developments that may impact its stock value or operational status.